International Prescription Sourcing: What You Should Know About Upcoming Changes
Prescription drug affordability remains a top concern across the board and international prescription sourcing has historically been one strategy used to help reduce costs for certain medications.
As the market continues to evolve, upcoming regulatory changes are drawing attention across the pharmacy landscape and prompting organizations to evaluate potential impacts on international sourcing programs.
What’s Changing?
Beginning January 20, 2027, new U.S. Customs and Border Protection (CBP) requirements are scheduled to take effect for low-value imports. Historically, many of these shipments moved through more streamlined entry pathways. As the updated requirements are implemented, stakeholders are evaluating how they may affect the processing of certain prescription medications shipped from international pharmacies upon entry into the United States.
The updated process may introduce additional customs documentation and review requirements, potentially creating new operational considerations for organizations that utilize international prescription sourcing programs. Many stakeholders are evaluating how current models may need to adapt.
What We’re Watching
At Candesa, we continuously monitor market and regulatory developments that may influence pharmacy benefit strategies. As these changes unfold, we’re focused on:
- Regulatory Interpretation: Understanding how this impacts fulfillment pathways.
- Vendor adaptation: How international sourcing vendors adjust fulfillment models and member support processes.
- Member experience: Potential impacts on medication access, communications, and delivery timelines.
- Alternative cost-management strategies: How stakeholders across the pharmacy ecosystem respond as the market evolves.
- Affordability and access trends: Ongoing discussions among policymakers, employers, and industry stakeholders.
Why This Matters
The recent developments affecting international prescription sourcing highlight the complexity and pace of change in today’s pharmacy marketplace. While questions remain about how organizations will adapt to the updated requirements, one thing is clear: staying informed is essential for making strategic pharmacy benefit decisions.
Our pharmacy experts will continue to monitor the market, assess developments objectively, and provide actionable insights that help employers navigate an increasingly dynamic pharmacy landscape.
Have questions or want to learn more about cost-containment strategies?
Connect with our team to hear how we’re helping employer groups navigate market challenges and reduce pharmacy spend.